Get started
XTL Biopharmaceuticals Ltd.XTL Biopharmaceuticals Ltd.XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

No trades
No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Compare with XTL Biopharmaceuticals Ltd.



Key stats


Market capitalization
‪8.19 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−765.02 K‬ USD
Revenue (FY)
0.00 USD
Shares float
‪4.14 M‬
Beta (1Y)
1.28

Company info


Sector
Health Technology
Industry
Medical Specialties
CEO
Noam Band
Website
xtlbio.com
Headquarters
Ramat Gan
Founded
1993
ISIN
US98386D4060
CUSIP
98386D406
FIGI
BBG000F1JVP4
Identifiers
ISIN US98386D4060
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.